Journal List > Korean J Gastroenterol > v.69(5) > 1007642

See the article "".
TOOLS
Heo: The Clinical Impact of AST-Platelet Ratio Index for Non-invasive Hepatic Fibrosis in the Patients with Chronic Hepatitis B
Editorial

The Korean Journal of Gastroenterology 2017; 69(5): 267-269.

Published online: 25 May 2017

DOI: https://doi.org/10.4166/kjg.2017.69.5.267

The Clinical Impact of AST-Platelet Ratio Index for Non-invasive Hepatic Fibrosis in the Patients with Chronic Hepatitis B

Nae-Yun Heo

Department of Internal Medicine, Inje University Haeundae Paik Hospital, Busan, Korea.

Correspondence to: Nae-Yun Heo, Department of Internal Medicine, Inje University Haeundae Paik Hospital, 875 Haeun-daero, Haeundae-gu, Busan 48108, Korea. Tel: +82-51-797-1340, Fax: +82-51-797-0298, nyheo@hanmail.net

Copyright © 2017. Korean Society of Gastroenterology

(open-access):

This is an open access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
Article: The Performance of Serum Biomarkers for Predicting Fibrosis in Patients with Chronic Viral Hepatitis ([Related article:] Korean J Gastroenterol 2017;69:298-307)

Notes

Financial support None.

Conflict of interest None.

References

1. Bravo AA, Sheth SG, Chopra S. Liver biopsy. N Engl J Med. 2001; 344:495–500.
2. Chen YP, Peng J, Hou JL. Non-invasive assessment of liver fibrosis in patients with chronic hepatitis B. Hepatol Int. 2013; 7:356–368.
3. Shin JW, Park NH. Clinical application of non-invasive diagnostic tests for liver fibrosis. Korean J Gastroenterol. 2016; 68:4–9.
4. Wai CT, Greenson JK, Fontana RJ, et al. A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C. Hepatology. 2003; 38:518–526.
5. Lin ZH, Xin YN, Dong QJ, et al. Performance of the aspartate aminotransferase-to-platelet ratio index for the staging of hepatitis C-related fibrosis: an updated meta-analysis. Hepatology. 2011; 53:726–736.
6. Sim SJ, Cheong JY, Cho SW, et al. Efficacy of AST to platelet ratio index in predicting severe hepatic fibrosis and cirrhosis in chronic hepatitis B virus infection. Korean J Gastroenterol. 2005; 45:340–347.
7. Shin WG, Park SH, Jang MK, et al. Aspartate aminotransferase to platelet ratio index (APRI) can predict liver fibrosis in chronic hepatitis B. Dig Liver Dis. 2008; 40:267–274.
8. Ucar F, Sezer S, Ginis Z, et al. APRI, the FIB-4 score, and Forn's index have noninvasive diagnostic value for liver fibrosis in patients with chronic hepatitis B. Eur J Gastroenterol Hepatol. 2013; 25:1076–1081.
9. Xiao G, Yang J, Yan L. Comparison of diagnostic accuracy of aspartate aminotransferase to platelet ratio index and fibrosis-4 index for detecting liver fibrosis in adult patients with chronic hepatitis B virus infection: a systemic review and meta-analysis. Hepatology. 2015; 61:292–302.
10. Guidelines for the prevention, care and treatment of persons with chronic hepatiti B infection. [Internet]. Geneva: World Health Organization (WHO);2015. 03. cited 2017 May 8. Available from: http://www.who.int/hepatitis/publications/hepatitis-b-guidelines/en/.
11. Kim WR, Berg T, Asselah T, et al. Evaluation of APRI and FIB-4 scoring systems for non-invasive assessment of hepatic fibrosis in chronic hepatitis B patients. J Hepatol. 2016; 64:773–780.
12. Bang CS, Kang HY, Choi GH, Kim SB, Lee W, Song IH. The Performance of Serum Biomarkers for Predicting Fibrosis in Patients with Chronic Viral Hepatitis. Korean J Gastroenterol. 2017; 69:298–307.
TOOLS
Similar articles